No Detail Found!

Antibiotic Susceptibility Pattern And Esbl Prevalence In Nosocomial Escherichia Coli From Urinary Tract Infection In Kpk, Peshawar

Author(s)
Muhammad Fawad Department of Health and Biological Sciences Abasyn University Peshawar, Khyber Pakhtunkhwa-25130-Pakistan
Noha E Abdel-razik Department of Medical Laboratory Technology, Faculty of Nursing and Health Sciences, Jazan University, Gizan, Saudi Arabia
Zain Alhindi Department of Clinical Laboratory Sciences, Faculty of Applied Medical Sciences, Umm Al-Qura University, Makkah, Saudi Arabia
Muhammad Usman Amin Department of Health and Biological Sciences Abasyn University Peshawar, Khyber Pakhtunkhwa-25130-Pakistan
Eman Adnan Abu-Seer Department of Epidemiology, Faculty of Public Health and Health Informatics Umm Al-Qura University Makkah, Saudi Arabia
Mashael S.Alfaifi Department of Epidemiology, Faculty of Public Health and Health Informatics Umm Al-Qura University Makkah, Saudi Arabia
Murad Ali Department of Zoology, Hazara University Mansehra Pakistan
Farkad Bantun Department of Microbiology and Parasitology, Faculty of Medicine, Umm Al-Qura University, Makkah, Saudi Arabia
Sheraz Dawar Department Allied Health Sciences Medical Lab Technology Sarhad University of Science and Information Technology Peshawar
Suleman Khan Department of Health and Biological Sciences Abasyn University Peshawar, Khyber Pakhtunkhwa-25130-Pakistan
Saad Alghamdi Department of Clinical Laboratory Sciences, Faculty of Applied Medical Sciences, Umm Al-Qura University, Makkah, Saudi Arabia
Abstract
The study aimed to evaluate antibiotic susceptibility patterns and extended-spectrum beta-lactamase prevalence in Escherichia coli isolated from urinary tract infections. Total fifty (50) samples of E. coli were obtained from urinary tract infection specimens in Hayatabad Medical Complex and private clinics in Peshawar, Pakistan. The present study obtained 50 E. coli isolates from 100 UTI specimens. The plates were incubated at 35 to 37°C for 24 to 48 hours. Different biochemical tests were carried out to identify the isolates. Antibiotic susceptibility testing and ESBL screening were done per the CLSI (2023) guidelines. The disc diffusion method was used to determine the antibiotic sensitivity pattern. In the present study, the highest ratio was 64 % (n=32), isolates showed resistance to 10 or more antibiotics, indicating them to be multi-drug resistant (MDR) isolates. Among the isolated E. coli strains, 64 % (n=32) were found to be ESBL producers, while the remaining 20 % (10) were found to be non-producers. Out of these 32 ESBL producer isolates, 09 (28.12 %) were positive on the confirmatory test, while the remaining 23(46 %) isolates were negative on the confirmatory test. Our result showed that (78 %) were sensitive to polymyxin B, while (70 %) were susceptible to Gentamicin and cefoperazone/sulbactam. Total (64 %) of the E. coli strains were ESBL producers. It was found that 32 % of ESBL-positive isolates were resistant to various types of antibiotics.
Publication Details
Page(s) 124-134
DOI DOI not available
Published Journal: Journal of Bioresource Management, Volume: 11, Issue: 3, Year: 2024

Request the full text from PASTIC

Keywords
ESBL, antibiotics susceptibility, Urinary tract infection., nosocomial Escherichia Coli
References
Abrar S,Ain NU,Liaqat H,Hussain S,Rasheed F,Riaz S .2019 .Distribution of bla CTX− M, bla TEM, bla SHV and bla OXA genes in Extended-spectrum-β-lactamaseproducing Clinical isolates: A three-year multi-center study from Lahore, Pakistan. Antimicrobial Resistance & Infection Control, 8(1) : 80.
Al-Badr A,Al-Shaikh G .2013 .Recurrent urinary tract infections management in women: a review. Sultan, 13(3) : 359.
Alqasim A,Abu Jaffal A,Alyousef A .2018 .Prevalence of Multidrug Resistance and ExtendedSpectrum β‐ Lactamase Carriage of Clinical Uropathogenic Escherichia coli Isolates in Riyadh, Saudi Arabia. 2018(1), : 3026851.
Azap K,Arslan H,Şerefhanoğlu K,Çolakoğlu Ş,Erdoğan H,Timurkaynak F,Senger S .2010 .Risk factors for extended-spectrum β-lactamase positivity in uropathogenic Escherichia coli isolated from community-acquired urinary tract infections. Clinical microbiology and infection, 16(2) : 147-151.
Bindayna M,Senok C,Jamsheer E .2009 .Prevalence of extended-spectrum beta-lactamase-producing Enterobacteriaceae in Bahrain. J. Infection and Public Health, 2(3) : 129-135.
Bonadio M,Meini M,Spitaleri P,Gigli C .2001 .Current microbiological and clinical aspects of urinary tract infections. European urology, 40(4) : 439-445.
Coque M,Baquero F,Canton R .2008 .Increasing prevalence of ESBLproducing Enterobacteriaceae in Europe. , 13(47) : 19044.
El Astal Y,Ramadan H Y .2008 .Occurrence of extended-spectrum beta-lactamases in isolates of Klebsiella pneumoniae and Escherichia coli. Int. J integr Bio, 2(2) : 122.
Harris N,Yin M,Jureen R,Chew J,Ali J,Paynter S,Tambyah A .2015 .Comparable outcomes for β- lactam/β-lactamase inhibitor combinations and carbapenems in definitive treatment of bloodstream infections caused by cefotaximeresistant Escherichia coli or Klebsiella pneumoniae. Antimicrobial resistance and infection control, 4(1) : 14.
Hassan A,Jamal A,Kamal M .2011 .Occurrence of multidrug resistant and ESBL producing E. coli causing urinary tract infections. J. of Basic & Applied Sciences, 7(1) : .
Hsueh R,Ko C,Wu J,Lu J,Wang D,Wu Y,Teng J .2010 .Consensus statement on the adherence to Clinical and Laboratory Standards Institute (CLSI) Antimicrobial Susceptibility Testing Guidelines (CLSI-2010 and CLSI-2010- update) for Enterobacteriaceae in clinical microbiology laboratories in Taiwan. J.Microbiology, Immunology and Infection, 43(5) : 452-455.
Marrs F,Zhang L,Foxman B .2005 .Escherichia coli mediated urinary tract infections: are there distinct uropathogenic E. coli (UPEC) pathotypes. FEMS microbiology letters, 252(2) : 183-190.
Okeke N,Laxminarayan R,Bhutta A,Duse G,Jenkins P,O'Brien F,Klugman P F .2005 .Antimicrobial resistance in developing countries. Part I: recent trends and current status. The Lancet infectious diseases, 5(8) : 481-493.
Paterson L,Bonomo A .2005 .Extendedspectrum β-lactamases: a clinical update. Clinical microbiology reviews, 18(4) : 657-686.
Prestinaci F,Pezzotti P,Pantosti A,H. A .2018 .Escherichia coli in Iran: An Overview of Antibiotic Resistance: A Review Article. Iranian journal of public health, 47(1) : 1-318.
Ramírez-Castillo F,Moreno-Flores F,Avelar-González F,Márquez-Díaz F,Harel J,Guerrero-Barrera A .2018 .An evaluation of multidrug-resistant Escherichia coli isolates in urinary tract infections from Aguascalientes, Mexico: cross-sectional study. Annals of clinical microbiology and antimicrobials, 17(1) : 34.
Riaz S,Bashir M .2015 .Phenotypic and molecular characterization of plasmid-encoded extended spectrum beta-lactamases produced by Escherichia coli and Klebsiella spp from Lahore, Pakistan. Tropical J. Pharm. Research, 14(9) : 1597-1604.
Sharma A,Bhat G,Shenoy S .2007 .Virulence factors and drug resistance in Escherichia coli isolated from extraintestinal infections. Indian J. medical microbiology, 25(4) : 369-373.
Sharma A,Bhatta R,Shrestha J,Banjara M .2013 .Antimicrobial susceptibility pattern of Escherichia coli isolated from urinary tract infected patients attending Bir Hospital. Nepal J Sci Technol, 14(1) : 177-8.
Shaikh S,Fatima J,Shakil S,Rizvi D,Kamal M .2015 .Antibiotic resistance and extended spectrum beta-lactamases: Types, epidemiology and treatment. Saudi J. biological sci, 22(1) : 90-101.
Singh M,Singh H .2014 .Comparative evaluation of six phenotypic methods for detecting extendedspectrum beta-lactamase-producing Enterobacteriaceae. The J. Infection in Developing Countries, 8(04) : 408-415.
Trevor A,Katzung B,Master B,Kruidering-Hall M,McGraw-Hill Medical M .2010 .Pharmacology examination & board review. , : .
Ullah F,Malik S,Ahmed J .2009 .Antibiotic susceptibility pattern and ESBL prevalence in nosocomial Escherichia coli from urinary tract infections in Pakistan. African J. Biotech, 8(16) : .
Wilson L,Gaido L. .2004 .Laboratory diagnosis of urinary tract infections in adult patients. Clinical infectious diseases, 38(8) : 1150-1158.
Nasser M,Palwe S,Bhargava N,Feuilloley G,Kharat S. .2020 .Retrospective analysis on antimicrobial resistance trends and prevalence of β-lactamases in Escherichia coli and ESKAPE pathogens isolated from Arabian patients during 2000- 2020. , 8(10) : 1626.
Moglad H ,Microbio Sudan. Intern. J. .2020 .Antibiotics profile, prevalence of extended-spectrum beta-lactamase (ESBL), and multidrug-resistant Enterobacteriaceae from different clinical samples in Khartoum State. , : .
Hashemizadeh Z,Mansouri S,Pahlavanzadeh F,MoronesRamírez R,Tabatabaeifar F,Motamedifar M,D M .2020 .Evaluation of chromosomally and acquired mechanisms of resistance to carbapenem antibiotics among clinical isolates of Pseudomonas aeruginosa in Kerman, Iran. Gene Reports, 21 : 100918.
Tasleem S,Moon S.,Alghamdi S,Ateeq R S,Salman M,Bantun M,F M .2022 .Presence of BlaPER-1 and BlaVEB-1 Beta-Lactamase Genes among Isolates of Pseudomonas Aeruginosa from Burn and Trauma Hospital Peshawar, Pakistan. J. Bioresource Management, 9(2) : 15.
Hariri S,Khan S,Biology Molecular .2023 .Physiology. , 15(1) : 259-265.
Shariati A,Arshadi M,Khosrojerdi M,Abedinzadeh M,Ganjalishahi M,Maleki A,Khoshnood S .2022 .The resistance mechanisms of bacteria against ciprofloxacin and new approaches for enhancing the efficacy of this antibiotic. Frontiers in public health, 10 : 1025633.
0

Citations

0

Downloads

84

Views